Article Sidebar
Article Details
Copyright of articles published shall reside exclusively with the Faculty of Pharmaceutical Sciences, University of Jos.
DECLARATION & COPYRIGHT TRANSFER
I/We the undersigned author(s) of article entitled
…………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………
Declare as follows:
- The manuscript submitted to Journal of Pharmacy & Bioresources is original and has not been and will be published, whole or in part, in print or electronic format, in any other journal. It is also not being currently considered for publication in any journal.
- The submitted manuscript is a joint decision of all the coauthors.
- Each author has participated sufficiently in the work to warrant his or her inclusion in the list of authors. To this end, each author takes responsibility for appropriate portions of the manuscript.
- Authors have obtained necessary approval to carry out the experiments on animals and human subjects. Approval certificates will be furnished, if required by publishers or editors of the journal.
- Authors do not have any conflict of interest (financial or otherwise) other than those declared.
- If the manuscript is accepted for publication, the authors transfer and assign copyright of the article referenced above to Journal of Pharmacy and Bioresources.
Name & Signature of authors
1. 2.
- 4.
- 6.
- 8.
Corresponding authors name address, affiliation and email:
Main Article Content
Anti retroviral drug prophylaxis in prevention of mother-to-child transmission of HIV infection in a treatment centre in Jos, Nigeria
Abstract
Prevention of mother-to-child transmission through the use of antiretroviral (ARV) prophylaxis has been identified as one of the ways of reducing prevalence of HIV/AIDS in children and many centers are implementing it. A study to assess the use and effectiveness of antiretrovirals in the prevention of mother-to-child transmission (PMTCT) in a treatment center in Jos, Nigeria, was carried out. The prophylaxis given to HIV positive mothers and their babies were reviewed over a 20 months period (Jan 2009 to August 2011) and the outcome of the intervention was assessed. Of the 135 pregnant mothers’ records reviewed, all of them were on triple ARV before delivery with 2 of them on second line regimen. The study revealed that 221 babies were given post exposure prophylaxis of single dose nevirapine at birth followed by 7 day course of zidovudine (AZT). Out of these babies 96.4% (213) returned negative Polymerase Chain Reaction (PCR) test results for HIV (P<0.01). The breast feeding options showed that 35.5% were on mixed or exclusive breastfeeding; 21% were on infant formula. The antiretroviral prophylaxis to the mothers and infants was given in accordance with recommended guidelines and was effective in reducing the perinatal transmission of HIV to the babies.
Keywords: Peri-natal transmission; ARVs; PMTCT
